ArticleFrontiers in medicine2025

Sequential tyrosine kinase inhibitor therapy for EGFR L747P-mutated lung adenocarcinoma in a renal transplant recipient: a 24-month case report.

Wenxiu Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.